Hinova Pharmaceuticals Inc. (SHA:688302)
China · Delayed Price · Currency is CNY 30.19
-0.62 (-2.01%)
Oct 13, 2026, 4:00 PM EDT
Hinova Pharmaceuticals Market Cap
Hinova Pharmaceuticals has a market cap or net worth of 2.99 billion as of October 13, 2026. It is the 15,620th most valuable company in the world and the 4,288th biggest in China. Its market cap has decreased by 40.61% in one year.
Market Cap
2.99B
Enterprise Value
2.31B
Revenue
62.27M
Global Rank
Country Rank
#4,288 China
PE Ratio
n/a
ChartMarket Cap Chart
Since April 12, 2022, Hinova Pharmaceuticals's market cap has increased from 2.98B to 2.99B, an increase of 0.30%. That is a compound annual growth rate of 0.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 2.99B | -38.60% |
| Dec 31, 2025 | 4.87B | 60.11% |
| Dec 31, 2024 | 3.04B | -41.02% |
| Dec 29, 2023 | 5.16B | 29.14% |
| Dec 30, 2022 | 3.99B | 33.95% |
| Apr 12, 2022 | 2.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Qingdao Vland Biotech INC. | 3.37B |
| Lifecome Biochemistry | 3.31B |
| Jiangsu Bioperfectus Technologies | 3.27B |
| Baolingbao Biology | 3.20B |
| Guanhao Biotech | 3.15B |
| Beijing Kawin Technology Share-Holding | 2.97B |
| Zhejiang Shouxiangu Pharmaceutical | 2.96B |
| Shanghai Universal Biotech | 2.90B |